Sydney + 61.2.8272.0327

Samin Raihan has substantial intellectual property experience in multiple jurisdictions involving the full spectrum of IP rights, with a particular focus on high-value patent and trademark disputes.

Samin has represented clients across almost every IP-driven industry, including the pharmaceutical, mining, fashion, hospitality, and technology sectors. He also has experience advising on brand protection, trademark prosecution, commercial/IP agreements, consumer law, and marketing matters.

Prior to joining Jones Day, Samin practiced at leading boutique and international law firms in Australia and the United Arab Emirates. In 2016, Samin was awarded Australia's Lawyers Weekly "Top 30 Under 30" award in the IP law category.


  • UPL sells stake in Advanta Enterprises to KKRJones Day advised UPL Limited in its $300 million sale of a 13.33% stake in its subsidiary, Advanta Enterprises Limited, to KKR.
  • Andrew Dzurak and Allectus Capital create leading quantum computing company, Diraq Pty LtdJones Day acted for Professor Andrew Dzurak and Allectus Capital, in the creation of a leading quantum computing company, Diraq Pty Ltd (formerly, SiMOS Newco Pty Ltd) whose founding shareholders consist of the University of New South Wales, Allectus Capital and Professor Dzurak.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Procter & Gamble acquires VOOSTJones Day advised The Procter & Gamble Company in its acquisition of VOOST Vitamins, Australia's leading effervescent supplements brand.